Bedromed portfolio
Bedromed is Bedrocan’s next evolution in cannabis medicines. This product line consists of standardised cannabinoid-based formulations derived from Bedrocan’s trusted cannabis Active Pharmaceutical Ingredients (APIs). Designed for a wide range of therapeutic applications, Bedromed offers a distinct and reliable portfolio that enables strong market differentiation and provides high-quality, recognisable solutions backed by a well-established brand.
Bedromed drops & Bedromed spray
Bedromed is available in oromucosal drops and a sublingual spray. Both products are available with different THC:CBD ratios: high-CBD, balanced, and high-THC. Additional pack sizes or strengths may be introduced in the future based on demonstrated clinical and commercial demand.
The Bedromed portfolio currently available is listed below.
Bedromed drops
Oromucosal drops
Formulated from Bedrocan’s renowned Bedrocan® chemovar, Bedromed drops provide a versatile format that supports both direct dispensing and pharmacy compounding, depending on local market requirements.
| Brand Name | Active Substance | Formulation | Starting Material* | Carrier Oil | |
|---|---|---|---|---|---|
 |
Bedromed drops | THC | 25 mg/mL | Bedrocan® | MCT |
 |
Bedromed drops | THC CBD |
10 mg/mL 10 mg/mL |
Bedrocan® | MCT |
|
Bedromed drops | THC CBD |
25 mg/mL 25 mg/mL |
Bedrocan® | MCT |
= THC dominant
= Balanced
*) Bedrocan®, Cannabis sativa L. ‘Afina’
Bedromed spray
Sublingual spray
The spray is designed to meet the needs of physicians and patients seeking rapid onset, flexible titration, and predictable dosing. Its formulation leverages proprietary technology to optimise cannabinoid absorption and stability.
| Brand Name | Active Substance |
Formulation | Starting Material* |
Carrier Oil |
|
|---|---|---|---|---|---|
|
Bedromed spray | THC | 20 mg/mL | Bedrocan® | LCT oil in water emulsion |
|
Bedromed spray | THC CBD |
10 mg/mL 10 mg/mL |
Bedrocan® Bedrolina® |
LCT oil in water emulsion |
 |
Bedromed spray | CBD | 20 mg/mL | Bedrocan® Bedrolina® |
LCT oil in water emulsion |
= THC dominant
= Balanced
= CBD dominant
*) Bedrocan®, Cannabis sativa L. ‘Afina’ | Bedrolina®, Cannabis sativa L. ‘Janna’
The products are supplied in a 30 mL pack size, designed to align with a typical 30-day treatment cycle and suitable for both reimbursed and private-pay settings, depending on local market frameworks.
Are you a patient?
We are a pharmaceutical manufacturer and only supply our products to licensed distributors and pharmacies. We do not sell directly to the public. If you are looking for treatment, please consult your doctor. They are the only ones who can assess your medical needs and provide a valid prescription. Your local pharmacist can then help you fulfill that prescription based on the regulations in your country.
